Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease
- PMID: 39688120
- DOI: 10.1111/eci.14373
Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease
Abstract
Lp(a): Lipoprotein (a). Created in BioRender. Romiti, G. (2024) BioRender.com/g02a734.
Keywords: Cardiovascular risk; Inflammation; Lipids.
© 2024 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Shi H, Xia Y, Cheng Y, et al. Global burden of ischaemic heart disease from 2022 to 2050: projections of incidence, prevalence, deaths, and disability‐adjusted life years. Eur Heart J Qual Care Clin Outcomes. 2024. doi:10.1093/ehjqcco/qcae049
-
- Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem. 2021;67(1):143‐153.
-
- Di Fusco SA, Maggioni AP, Scicchitano P, Zuin M, D'Elia E, Colivicchi F. Lipoprotein (a), inflammation, and atherosclerosis. J Clin Med. 2023;12(7):2529. doi:10.3390/jcm12072529
-
- Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride‐rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies‐a consensus statement from the European atherosclerosis society. Eur Heart J. 2021;42(47):4791‐4806.
-
- Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin‐6 in unstable angina. Circulation. 1996;94(5):874‐877.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
